Patrick Björkman

Patrick Björkman

Auto-generated profile, based on publicly available information

Patrick Björkman

University of Helsinki and Helsinki University Hospital

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 August 2005 in NeuroReport
Verified
Journal Article
Closed access
KKKalle Kotilahti
Kalle Kotilahti
INIlkka Nissilä
Ilkka Nissilä
MHMinna Huotilainen
Minna Huotilainen
RMRiikka Mäkelä
Riikka Mäkelä
NGNasia Gavrielides
Nasia Gavrielides
TKToivo Katila
Toivo Katila
We studied hemodynamic auditory evoked responses of 20 healthy full-term neonates with near-infrared spectroscopy. The instrument used allows the measurements to be performed simultaneously above both auditory cortices. The stimulation consisted of 5-s trains of sound (700-ms interstimulus interval) with a 25-s silent interval. In response to the stimulation, a significant increase in concentration of oxygenated hemoglobin was detected in 14 out of 21 measurements. The mean latency of the largest response was 9.63+/-2.20 s (mean+/-SD) and the mean amplitude was 1.02+/-0.53 microM. The response amplitude was significantly larger in active (1.28+/-0.59 microM) than in quiet sleep (0.76+/-0.32 microM). The latency of the oxygenated hemoglobin concentration response was significantly shorter (r=-0.70 and p=0.0023) for infants with higher gestational age.

5 September 2018 in Scandinavian Journal of Surgery
Verified
Journal Article
Closed access
PBP. Björkman
P. Björkman
EWE.-M. Weselius
E.-M. Weselius
TKT. Kokkonen
T. Kokkonen
VRV. Rauta
V. Rauta
AAA. Albäck
A. Albäck
MVM. Venermo
M. Venermo
Background and Aims: Stenosis due to intimal hyperplasia and restenosis after initially successful percutaneous angioplasty are common reasons for failing arteriovenous fistulas. The aim of this study was to evaluate the effect of drug-coated balloons in the treatment of arteriovenous fistula stenosis. Design: Single-center, parallel group, randomized controlled trial. Block randomized by sealed envelope 1:1. Materials and Methods: A total of 39 patients with primary or recurrent stenosis in a failing native arteriovenous fistulas were randomized to drug-coated balloon (n = 19) or standard balloon angioplasty (n = 20). Follow-up was 1 year. Primary outcome measure was target lesion revascularization. Results: In all, 36 stenoses were analyzed; three patients were excluded due to technical failure after randomization. A total of 88.9% (16/18) in the drug-coated balloon group was revascularized or occluded within 1 year, compared to 22.2% (4/18) of the stenoses in the balloon angioplasty group (relative risk for drug-coated balloon 7.09). Mean time-to- target lesion revascularization was 110 and 193 days after the drug-coated balloon and balloon angioplasty, respectively (p = 0.06). Conclusions: With 1-year follow-up, the target lesion revascularization-free survival after drug-coated balloon-treatment was clearly worse. The reason for this remains unknown, but it may be due to differences in the biological response to paclitaxel in the venous arteriovenous fistula-wall compared to its antiproliferative effect in the arterial wall after drug-coated balloon treatment of atherosclerotic occlusive lesions. Trial registration: ClinicalTrials.gov NCT03036241

4 June 2021 in Journal of Trauma and Acute Care Surgery
Verified
Journal Article
Open access
MTMatti Tolonen
Matti Tolonen
ALAurora Lemma
Aurora Lemma
PVPirkka Vikatmaa
Pirkka Vikatmaa
EPErno Peltola
Erno Peltola
PMPanu Mentula
Panu Mentula
VSVille Sallinen
Ville Sallinen
BACKGROUND: Acute mesenteric ischemia (AMI) is a disease with high mortality and requires a multidisciplinary approach for effective management. A pathway and care bundle were developed and implemented with the objective to reduce mortality. The aim of this retrospective comparative study was to analyze the effects of the pathway on patient management and outcome. METHODS: All consecutive patients operated in a secondary and tertiary referral center because of occlusive arterial AMI were identified between 2014 and April 2020. The pathway aimed to increase overall awareness, and hasten and improve diagnostics and management. Patients treated before implementation of the pathway (pregroup, years 2014–2017) were compared with patients treated using the pathway (postgroup, May 2018 to April 2020). Univariate and multivariate analyses were used to compare the groups. RESULTS: There were 78 patients in the pregroup and 67 patients in the postgroup with comparable baseline characteristics and disease acuity. The postgroup was more often diagnosed with contrast-enhanced computed tomography (58 [74%] vs. 63 [94%], p = 0.001) and had shorter mean in-hospital delay to operating room (7 hours [interquartile range, 3.5–12.5] vs. 3 hours [interquartile range, 2–11], p = 0.023). Revascularization was done more often in the postgroup (53 [68%] vs. 56 [84%], p = 0.030) especially using endovascular treatment (26 [33%] vs. 43 [64%], p < 0.001). Thirty-day mortality was lower in the postgroup (23 [51%] vs. 17 [25%], p = 0.001). Being managed in the postgroup remained as a protective factor (odds ratio, 0.32; 95% confidence interval, 0.14–0.75; p = 0.008) for 30-day mortality in the multivariate analysis. CONCLUSION: Implementing a pathway and care bundle resulted in enhanced regional and in-hospital awareness of AMI, more appropriate computed tomography imaging, shorter in-hospital delays, increased number of revascularizations, and, hence, lower mortality. LEVEL OF EVIDENCE: Therapeutic/Care Management, level IV.

15 May 2014 in Knee Surgery, Sports Traumatology, Arthroscopy
Verified
Journal Article
Closed access
PDF file
PBPatrick Björkman
Patrick Björkman
JSJerker Sandelin
Jerker Sandelin
AHArsi Harilainen
Arsi Harilainen

1 February 2019 in Annals of Vascular Surgery
Verified
Journal Article
Closed access
PBPatrick Björkman
Patrick Björkman
TKTatu Kokkonen
Tatu Kokkonen
AAAnders Albäck
Anders Albäck
MVMaarit Venermo
Maarit Venermo

1 November 2018 in Annals of Vascular Surgery
Verified
Journal Article
Closed access
PBPatrick Björkman
Patrick Björkman
TATommi Auvinen
Tommi Auvinen
HHHarri H. Hakovirta
Harri H. Hakovirta
PRPekka Romsi
Pekka Romsi
JTJohanna Turtiainen
Johanna Turtiainen
MVMaarit Venermo
Maarit Venermo